| 14102 | A | 091377 | 002 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 1GM BASE/VIAL | | [] | 2015-09-09 | Sep 9, 2015 | No | No | No | DISCN | XELLIA PHARMACEUTICALS APS | dbaac684df3857d968300460b07d43f69ae4a94138c6d6b8a4d833ecaa092d5d |
| 14103 | A | 204107 | 002 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 1GM BASE/VIAL | AP | ["AP"] | 2015-12-28 | Dec 28, 2015 | No | No | No | RX | XELLIA PHARMACEUTICALS APS | d56ce4944d826be9c24035d0665bed822eb90b02b512eb560379a922d327b810 |
| 14104 | A | 204125 | 001 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 5GM BASE/VIAL | AP | ["AP"] | 2015-12-28 | Dec 28, 2015 | No | No | No | RX | XELLIA PHARMACEUTICALS APS | a1c9d366c8a4787ab0a5af5067f73381affeee0df7581219a6b474f693d8a3b0 |
| 14105 | A | 206243 | 001 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 5GM BASE/VIAL | | [] | 2015-12-23 | Dec 23, 2015 | No | No | No | DISCN | XELLIA PHARMACEUTICALS APS | ae5acf8fe9d3b687e87c06b6bf9715b17bcc5af3130b9d0b4a9545f6062d9f3a |
| 14106 | A | 204125 | 002 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 10GM BASE/VIAL | AP | ["AP"] | 2015-12-28 | Dec 28, 2015 | No | No | No | RX | XELLIA PHARMACEUTICALS APS | ead5044e7266ad628aac7dfd4a3b5f279b3073b98de221a4cbb0ec75b3def442 |
| 14107 | A | 206243 | 002 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 10GM BASE/VIAL | | [] | 2015-12-23 | Dec 23, 2015 | No | No | No | DISCN | XELLIA PHARMACEUTICALS APS | 1ce3c00fd1199a59c0838f165f354460dde3795d85180034be2d616cc6dcbb7f |
| 14108 | A | 091377 | 001 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 500MG BASE/VIAL | | [] | 2015-09-09 | Sep 9, 2015 | No | No | No | DISCN | XELLIA PHARMACEUTICALS APS | 051b5296ee543b56b151916788da323460999ca5285ba7ab1e8420b1de0c95a0 |
| 14109 | A | 204107 | 001 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOMYCIN HYDROCHLORIDE | XELLIA PHARMS APS | EQ 500MG BASE/VIAL | AP | ["AP"] | 2015-12-28 | Dec 28, 2015 | No | No | No | RX | XELLIA PHARMACEUTICALS APS | 49020b163c43dbb3fcfb65140af9ade84b7cfe3b8abe50479a5fc34e4746b7ea |
| 14110 | A | 062956 | 002 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOR | PHARMACIA AND UPJOHN | EQ 1GM BASE/VIAL | | [] | 1988-08-01 | Aug 1, 1988 | No | No | No | DISCN | PHARMACIA AND UPJOHN CO | 199cac286e03510d405fd406e46fec41dcabf83c8892fbaecd1bcac8534cb5f6 |
| 14111 | A | 062956 | 001 | VANCOMYCIN HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VANCOR | PHARMACIA AND UPJOHN | EQ 500MG BASE/VIAL | | [] | 1988-08-01 | Aug 1, 1988 | No | No | No | DISCN | PHARMACIA AND UPJOHN CO | 76a5235ed787747d535a5bdd28328130dacb111f37de9be5fcf58a67c9c2a137 |
| 14112 | N | 016783 | 001 | IOTHALAMATE MEGLUMINE; IOTHALAMATE SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VASCORAY | MALLINCKRODT | 52%;26% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | MALLINCKRODT MEDICAL INC | d2411b6605bfc0f9c382ee1f63d8b99b08d7ac132bb15377fcc3ddc0f0abd7de |
| 14113 | N | 019309 | 001 | ENALAPRILAT | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VASOTEC | BIOVAIL LABS INTL | 1.25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1988-02-09 | Feb 9, 1988 | No | Yes | No | DISCN | BIOVAIL LABORATORIES INTERNATIONAL SRL | af085e00c90f66ec50a2edd038e4fd7ba7b02760262a58f822d51afaa31766b9 |
| 14114 | N | 006772 | 002 | METHOXAMINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VASOXYL | GLAXOSMITHKLINE | 10MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GLAXOSMITHKLINE | bf13aef6530677aeba004de16acb88b5ed2e3fed18173c17c47159c2392156f4 |
| 14115 | N | 006772 | 001 | METHOXAMINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VASOXYL | GLAXOSMITHKLINE | 20MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | GLAXOSMITHKLINE | 0d5bb02a3bc2f55e7f1a019a3a42a181aeddc1b124bbe20b2a5d96747a17273a |
| 14116 | A | 206670 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | AUROBINDO PHARMA LTD | 10MG/VIAL | AP | ["AP"] | 2018-12-20 | Dec 20, 2018 | No | No | No | RX | AUROBINDO PHARMA LTD | 9fb541e0897cb19f6a69594b668a6e1ed918371412500a97094311546373c9f4 |
| 14117 | A | 206670 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | AUROBINDO PHARMA LTD | 20MG/VIAL | AP | ["AP"] | 2018-12-20 | Dec 20, 2018 | No | No | No | RX | AUROBINDO PHARMA LTD | 82e259c079d6905da6e3246bf7da8b8ba8a2c515d1fe846c0150c46b8f0605cf |
| 14118 | A | 205390 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | GLAND PHARMA LTD | 10MG/VIAL | AP | ["AP"] | 2016-05-26 | May 26, 2016 | No | No | No | RX | GLAND PHARMA LTD | 9b0c6710907cbd27621376e5a605beecb83fcd2ce5b60500855daa3905e511db |
| 14119 | A | 205390 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | GLAND PHARMA LTD | 20MG/VIAL | AP | ["AP"] | 2016-05-26 | May 26, 2016 | No | No | No | RX | GLAND PHARMA LTD | 97e5df6f0fc51a7614fed5cfc747cbdd87d3aeb4f29c0efdc175d17f737a8d28 |
| 14120 | A | 203725 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | HIKMA | 10MG/VIAL | AP | ["AP"] | 2019-07-30 | Jul 30, 2019 | No | No | No | RX | HIKMA FARMACEUTICA PORTUGAL SA | b736eda055990cd24f800f293367dbe9e67068396f85c292574e5d5453b44967 |
| 14121 | A | 203725 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | HIKMA | 20MG/VIAL | AP | ["AP"] | 2019-07-30 | Jul 30, 2019 | No | No | No | RX | HIKMA FARMACEUTICA PORTUGAL SA | 635e14d73d03daad5161962dcd8167d42244a79bf24b3cf27f1ffe8c7e0b0c3d |
| 14122 | A | 075558 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | HOSPIRA | 4MG/VIAL | | [] | 2001-09-11 | Sep 11, 2001 | No | No | No | DISCN | HOSPIRA INC | a90385109a749a659542f019cf0ed34a8695a6124da8d9f0d956ea0c8fc0723d |
| 14123 | A | 075164 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | HOSPIRA | 10MG/VIAL | AP | ["AP"] | 1999-10-21 | Oct 21, 1999 | No | No | No | RX | HOSPIRA INC | b3c4924f4a97f1431587e4da4a88acfb8c06df422d123cce746a6bb5b40c5025 |
| 14124 | A | 075164 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | HOSPIRA | 20MG/VIAL | AP | ["AP"] | 1999-10-21 | Oct 21, 1999 | No | No | No | RX | HOSPIRA INC | 7396ff1a3a71b28fbe8436f89ff907438eeb3a206c5c558b961924778f34d688 |
| 14125 | A | 090243 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | MYLAN LABS LTD | 10MG/VIAL | AP | ["AP"] | 2010-05-11 | May 11, 2010 | No | No | No | RX | MYLAN LABORATORIES LTD | fc10a02ecd935900b7e7e5f3f91130a51c831fbdbfa12b028d069ece2b6ff5f9 |
| 14126 | A | 090243 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | MYLAN LABS LTD | 20MG/VIAL | AP | ["AP"] | 2010-05-11 | May 11, 2010 | No | No | No | RX | MYLAN LABORATORIES LTD | 5e8495489933d6dcbb166fe2367b2e7d580744ba99d1bd22a3c31cd119e77d2c |
| 14127 | A | 078274 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | SAGENT PHARMS INC | 10MG/VIAL | AP | ["AP"] | 2008-12-29 | Dec 29, 2008 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | e3c965bf0b66a3b44490e736b163008ed3fdb0d8c09af4c863f42661e7cbba0b |
| 14128 | A | 078274 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | SAGENT PHARMS INC | 20MG/VIAL | AP | ["AP"] | 2008-12-29 | Dec 29, 2008 | No | No | No | RX | SAGENT PHARMACEUTICALS INC | 2bf54bb7e5d08955fdb6068f435305f8ec6949c9b847b3273e23ba3ff5a0edd0 |
| 14129 | A | 079001 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | SUN PHARM | 10MG/VIAL | AP | ["AP"] | 2009-06-17 | Jun 17, 2009 | No | No | Yes | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 9b35be1bc91e0a344551552c20e581de869682a4ed4376ef3a40209303ba0fb5 |
| 14130 | A | 079001 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | SUN PHARM | 20MG/VIAL | AP | ["AP"] | 2009-06-17 | Jun 17, 2009 | No | No | Yes | RX | SUN PHARMACEUTICAL INDUSTRIES LTD | 29de38d255069abb17366d7162218b2313d9b0bbd9d22e00dc6be7dc1c82803d |
| 14131 | A | 074688 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | TEVA PHARMS USA | 10MG/VIAL | AP | ["AP"] | 1999-08-25 | Aug 25, 1999 | No | No | No | RX | TEVA PHARMACEUTICALS USA | 3c8108ded135fd8f8a6974b83c99b46145c19928f0cb6baa9454fa13ba2f988b |
| 14132 | A | 074688 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | TEVA PHARMS USA | 20MG/VIAL | AP | ["AP"] | 1999-08-25 | Aug 25, 1999 | No | No | No | RX | TEVA PHARMACEUTICALS USA | dbe6261a7d7bb5cafbde6ec4767e6d42ebe85923da29ad6a228e5fa904265d34 |
| 14133 | A | 074334 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WATSON LABS | 10MG/VIAL | | [] | 1995-08-31 | Aug 31, 1995 | No | No | No | DISCN | WATSON LABORATORIES INC | e07da696096c3a4fd290ad36b450fe07f22ec393539e19c979eb6662312edce3 |
| 14134 | A | 074334 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WATSON LABS | 20MG/VIAL | | [] | 1995-08-31 | Aug 31, 1995 | No | No | No | DISCN | WATSON LABORATORIES INC | 136b36dec47c07b2ca34abc5e9eca750a08eaca83a4c4d8f6367694bb662b353 |
| 14135 | A | 075218 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WEST-WARD PHARMS INT | 10MG/VIAL | | [] | 1999-08-23 | Aug 23, 1999 | No | No | No | DISCN | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | af570446958ca768a8ed6b72ca152b4efed506f5567d0ef7b97bda371d78527d |
| 14136 | A | 075549 | 001 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WEST-WARD PHARMS INT | 10MG/VIAL | AP | ["AP"] | 2000-06-13 | Jun 13, 2000 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 597e40c99ad4895658faf725a59d3d6a6e93c25cdf21f30a6a362ea0bc1cd01e |
| 14137 | A | 075218 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WEST-WARD PHARMS INT | 20MG/VIAL | | [] | 1999-08-23 | Aug 23, 1999 | No | No | No | DISCN | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | 49b00ba478521dc41645b2a6a5b5dc807242efc6fffd628c9c4185ffa72f203f |
| 14138 | A | 075549 | 002 | VECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VECURONIUM BROMIDE | WEST-WARD PHARMS INT | 20MG/VIAL | AP | ["AP"] | 2000-06-13 | Jun 13, 2000 | No | No | No | RX | WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD | f6ddb7446f797ac75c7ca5e64733983cba21ff9ce04f75fc3dc3a4a10db6f2af |
| 14139 | N | 017957 | 001 | AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; POTASSIUM CHLORIDE; SODIUM ACETATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VEINAMINE 8% | HOSPIRA INC | 8%;61MG/100ML;211MG/100ML;56MG/100ML;388MG/100ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOSPIRA INC | ee08c32fb1c568439770eaaab3f88f2f8351a60497a5e1e6f5ded6b8858b4b58 |
| 14140 | N | 012665 | 001 | VINBLASTINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELBAN | LILLY | 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | ELI LILLY AND CO | 42cfada91b28aedc9ff8041e7803771c7881f2a5373fc5cf7748ad3af80b1888 |
| 14141 | N | 022260 | 002 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELETRI | ACTELION | EQ 0.5MG BASE/VIAL | AP2 | ["AP2"] | 2012-06-28 | Jun 28, 2012 | No | Yes | Yes | RX | ACTELION PHARMACEUTICALS US INC | 82d9f3837ba1a4d922c2227cf600be18bcd51aa940ef43ca389b8a9103c9cac9 |
| 14142 | N | 022260 | 001 | EPOPROSTENOL SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELETRI | ACTELION | EQ 1.5MG BASE/VIAL | AP2 | ["AP2"] | 2008-06-27 | Jun 27, 2008 | No | Yes | Yes | RX | ACTELION PHARMACEUTICALS US INC | 9ba84f26741a39798fd655c6b02ea51ceab272aefe54e35cf0d6545dcb0779f6 |
| 14143 | A | 061976 | 004 | CEPHRADINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELOSEF | APOTHECON | 1GM/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | e4580e5fc147edfe9dd204ac6433b572645f88bed26c40679b51189ae9275aed |
| 14144 | A | 061976 | 003 | CEPHRADINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELOSEF | APOTHECON | 2GM/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | d387aa5f09294b97741e905d0328b5c42d1f25001ec014588a474129672a7e81 |
| 14145 | A | 061976 | 005 | CEPHRADINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELOSEF | APOTHECON | 4GM/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | 51119e81bdd25a09232570e735727dc1aaf0f2c3b536b4cc4e606a2429b6143c |
| 14146 | A | 061976 | 001 | CEPHRADINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELOSEF | APOTHECON | 250MG/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | b3aa9a74251096ba7d870c8b72bdb498c57968bdb00f6df1da8ba7c9cda6b19f |
| 14147 | A | 061976 | 002 | CEPHRADINE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VELOSEF | APOTHECON | 500MG/VIAL | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | APOTHECON INC DIV BRISTOL MYERS SQUIBB | c9beeb399934ad59dff490b97bfa0877fbf1c199e6c7be0b79b4c45257260a76 |
| 14148 | N | 018768 | 001 | ETOPOSIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VEPESID | CORDEN PHARMA | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1983-11-10 | Nov 10, 1983 | No | Yes | No | DISCN | CORDEN PHARMA LATINA SPA | 502e68c702629a01ff29ac53a5ee65aa50c58a3ddea2c04757394ad700b34283 |
| 14149 | A | 070348 | 001 | VERAPAMIL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VERAPAMIL HYDROCHLORIDE | ABRAXIS PHARM | 2.5MG/ML | | [] | 1986-05-01 | May 1, 1986 | No | No | No | DISCN | ABRAXIS PHARMACEUTICAL PRODUCTS | a35c6d12d0cb8717568cbcd7a5027e23f0f9160e20e871f2223b7ac602bf3115 |
| 14150 | A | 212965 | 001 | VERAPAMIL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VERAPAMIL HYDROCHLORIDE | AUROBINDO PHARMA LTD | 2.5MG/ML | AP | ["AP"] | 2020-07-06 | Jul 6, 2020 | No | No | Yes | RX | AUROBINDO PHARMA LTD | 83f0ad39a9dfbfef387dbd7d8fcceb8bf7c27505406d891c1cc58b9570a3023b |
| 14151 | A | 072888 | 001 | VERAPAMIL HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | VERAPAMIL HYDROCHLORIDE | BEDFORD | 2.5MG/ML | | [] | 1995-07-28 | Jul 28, 1995 | No | No | No | DISCN | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | ef8e92d68e0c0f3cb82e08d726aa1a77f0d66e5385fe6593bc5a43be417a3e9d |